CORC

在结果中检索

CORC

浏览/检索结果: 共39条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Cytotoxicity and Bonding Property of Bioinspired Nacre-like Ceramic-Polymer Composites 期刊论文
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2022, 卷号: 10, 页码: 12
作者:  Sun, Hui;  Gao, Kefeng;  Yi, Zhe;  Han, Chengwei;  Liu, Zengqian
收藏  |  浏览/下载：306/0  |  提交时间：2022/07/14
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 期刊论文
JOURNAL OF HEPATOLOGY, 2019, 卷号: 70
作者:  Gong, Guozhong;  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun
收藏  |  浏览/下载：61/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：50/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：39/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：41/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：33/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：32/0  |  提交时间：2019/12/05
A new diagrammatic method for the prediction of solid solubility in Mg alloys based on the short-range ordered structure 期刊论文
COMPUTATIONAL MATERIALS SCIENCE, 2019, 卷号: 159, 页码: 32-42
作者:  Zhou, Jixue;  Wang, Jin;  Qin, Jingyu;  Cheng, Kaiming;  Zhan, Chengwei
收藏  |  浏览/下载：112/0  |  提交时间：2019/12/11
The Medication Risk of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis in Asians: The Major Drug Causality and Comparison With the US FDA Label 期刊论文
Clinical Pharmacology & Therapeutics, 2019, 卷号: Vol.105 No.1, 页码: 112-120
作者:  Yu‐Hsin Wang;  Chun‐Bing Chen;  Wichittra Tassaneeyakul;  Yoshiro Saito;  Michiko Aihara
收藏  |  浏览/下载：24/0  |  提交时间：2019/12/13
Evaluation of groundwater discharge into surface water by using Radon-222 in the Source Area of the Yellow River, Qinghai-Tibet Plateau 期刊论文
JOURNAL OF ENVIRONMENTAL RADIOACTIVITY, 2018, 卷号: 192, 页码: 257-266
作者:  Yi, Peng;  Luo, Huan;  Chen, Li;  Yu, Zhongbo;  Jin, Huijun
收藏  |  浏览/下载：61/0  |  提交时间：2019/10/09

©版权所有 ©2017 CSpace - Powered by CSpace